Literature DB >> 6164722

Alternative induction of IFN-alpha and IFN-gamma by Listeria monocytogenes in human peripheral blood mononuclear leukocyte cultures.

A Nakane, T Minagawa.   

Abstract

Production of interferon (IFN) by Listeria monocytogenes (LM) in human peripheral blood mononuclear leukocyte (PBML) cultures was studied. Acid-labile IFN-gamma was produced in Ficoll-Hypaque-purified mononuclear cell cultures in response to heat-killed LM (HK-LM). However, plastic dish (PD)-nonadherent cells produced acid-stable IFN-alpha, whereas the cells reconstituted with PD-adherent cells (M phi) and PD-nonadherent cells produced IFN-gamma by HK-LM, IFN-gamma was produced only in a mixture of SRBC rosette-forming (T) cells and M phi. Neither T cells nor M phi produced IFN by HK-LM. On the other hand, IFN-alpha was produced from non-T and nylon wool-nonadherent (non-T, non-B) cells by stimulation with HK-LM in the absence of M phi. A reciprocal type of IFN produced in human PBML was absolutely dependent on the presence or absence of M phi. A soluble fraction extracted from sonically disrupted LM had a high potential to induce IFN-gamma in human PBML. Possible mechanism of the alternative production of IFN-gamma or IFN-alpha in human PBML by Listeria are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164722

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

Authors:  Lis R V Antonelli; Antonio Gigliotti Rothfuchs; Ricardo Gonçalves; Ester Roffê; Allen W Cheever; Andre Bafica; Andres M Salazar; Carl G Feng; Alan Sher
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

2.  Undermethylation of interferon-gamma gene in human T cell lines and normal T lymphocytes.

Authors:  R Fukunaga; M Matsuyama; H Okamura; K Nagata; S Nagata; Y Sokawa
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

3.  Role of tumor necrosis factor in Listeria resistance of nude mice.

Authors:  T Hauser; K Frei; R M Zinkernagel; T P Leist
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

Review 4.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Induction of alpha and beta interferons during the hyporeactive state of gamma interferon by Mycobacterium bovis BCG cell wall fraction in Mycobacterium bovis BCG-sensitized mice.

Authors:  A Nakane; T Minagawa
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Recombinant murine gamma interferon induces enhanced resistance to Listeria monocytogenes infection in neonatal mice.

Authors:  Y Chen; A Nakane; T Minagawa
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  Prevention by gamma interferon of fatal infection with Listeria monocytogenes in mice treated with cyclosporin A.

Authors:  A Nakane; T Minagawa; I Yasuda; C Yu; K Kato
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

8.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

9.  Listeria monocytogenes activation of human peripheral blood lymphocytes: induction of non-major histocompatibility complex-restricted cytotoxic activity and cytokine production.

Authors:  Y Guo; D W Niesel; H K Ziegler; G R Klimpel
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

10.  Activation of natural resistance against lung metastasis of an adenocarcinoma in T-cell depressed spontaneously hypertensive rats by infection with Listeria monocytogenes.

Authors:  Y Koga; J Hamada; N Takeichi; A Nakane; T Minagawa; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.